# NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions

> **NCT00231283** · PHASE3 · COMPLETED · sponsor: **Cordis US Corp.** · enrollment: 100 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** CYPHER NxT SES ON BX SONIC OTW STENT DELIVERY SYSTEM (SDS)

## Key facts

- **NCT ID:** NCT00231283
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2010-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231283, "NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00231283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*